Sonalasense Achieves Significant Clinical, Growth And Funding Milestones Toward Its Mission To Soundly Defeat Cancer

SonALAsense, a pioneer in the development of SONALA-001 and sonodynamic therapy (SDT), a new drug-device combination developed to manage deadly cancers so patients can become survivors, today announced clinical, organizational and growth updates. It is the only company with SDT in clinical trials.